Refining Your Drug Candidates Through Pre-Clinical Lead Optimization to Ensure Translational Success – Dive into the Discussions
Time: 2:00 pm
day: Workshop C
Details:
Refining potential drug targets before they advance to costly and time-intensive clinical trials is important. With more organizations working across novel targeting agents, further radioisotopes, new linkers and chelators – lead optimization is integral for translational success leading to the development of safer and more effective drugs for patients.
Join this interactive workshop to hear more on:
- Uncovering preclinical evaluation processes to select efficiently good radiolabeled molecules
- Assessing the addition of linkers and choice of chelating agent
- Screening combinations of radiometal complexes, linker and conjugation function
- Novel platforms to design new molecules
- Enhancing PKPD, binding affinity and biodistribution
- Assessing and mitigating your translational risk
